These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29296971)

  • 41. Publisher's Note: Thermally Mediated Mechanism to Enhance Magnetoelectric Coupling in Multiferroics [Phys. Rev. Lett. 114, 177205 (2015)].
    Chang CM; Mani BK; Lisenkov S; Ponomareva I
    Phys Rev Lett; 2016 Jan; 116(1):019905. PubMed ID: 26799053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Publisher's Note: Generating functionals and Gaussian approximations for interruptible delay reactions [Phys. Rev. E 92, 042105 (2015)].
    Brett T; Galla T
    Phys Rev E Stat Nonlin Soft Matter Phys; 2015 Oct; 92(4):049902. PubMed ID: 26565372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Publisher's Note: Direct Imaging of Dynamic Glassy Behavior in a Strained Manganite Film [Phys. Rev. Lett. 115, 265701 (2015)].
    Kundhikanjana W; Sheng Z; Yang Y; Lai K; Ma EY; Cui YT; Kelly MA; Nakamura M; Kawasaki M; Tokura Y; Tang Q; Zhang K; Li X; Shen ZX
    Phys Rev Lett; 2016 Jan; 116(1):019904. PubMed ID: 26799052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Publisher's Note: Role of connectivity and fluctuations in the nucleation of calcium waves in cardiac cells [Phys. Rev. E 92, 052715 (2015)].
    Hernandez-Hernandez G; Alvarez-Lacalle E; Shiferaw Y
    Phys Rev E Stat Nonlin Soft Matter Phys; 2015 Dec; 92(6):069902. PubMed ID: 26764861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Publisher's Note: Candidate Source of Flux Noise in SQUIDs: Adsorbed Oxygen Molecules [Phys. Rev. Lett. 115, 077002 (2015)].
    Wang H; Shi C; Hu J; Han S; Yu CC; Wu RQ
    Phys Rev Lett; 2015 Dec; 115(24):249901. PubMed ID: 26705662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Publisher's Note: Colloidal interactions in a homeotropic nematic cell with different elastic constants [Phys. Rev. E 92, 042505 (2015)].
    Tovkach OM; Chernyshuk SB; Lev BI
    Phys Rev E Stat Nonlin Soft Matter Phys; 2015 Nov; 92(5):059903. PubMed ID: 26651819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Publisher's Note: Dynamic model of target charging by short laser pulse interactions [Phys. Rev. E 92, 043107 (2015)].
    Poyé A; Dubois JL; Lubrano-Lavaderci F; D'Humières E; Bardon M; Hulin S; Bailly-Grandvaux M; Ribolzi J; Raffestin D; Santos JJ; Nicolaï P; Tikhonchuk V
    Phys Rev E Stat Nonlin Soft Matter Phys; 2015 Nov; 92(5):059902. PubMed ID: 26651818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The bone-marrow niche in MDS and MGUS: implications for AML and MM.
    Ghobrial IM; Detappe A; Anderson KC; Steensma DP
    Nat Rev Clin Oncol; 2018 Apr; 15(4):219-233. PubMed ID: 29311715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma.
    Merz M; Jauch A; Hielscher T; Bochtler T; Schönland SO; Seckinger A; Hose D; Bertsch U; Neben K; Raab MS; Hillengass J; Salwender H; Blau IW; Lindemann HW; Schmidt-Wolf IGH; Scheid C; Haenel M; Weisel KC; Goldschmidt H
    Blood Adv; 2018 Jan; 2(1):1-9. PubMed ID: 29344579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients.
    Jurczyszyn A; Radocha J; Davila J; Fiala MA; Gozzetti A; Grząśko N; Robak P; Hus I; Waszczuk-Gajda A; Guzicka-Kazimierczak R; Atilla E; Mele G; Sawicki W; Jayabalan DS; Charliński G; Szabo AG; Hajek R; Delforge M; Kopacz A; Fantl D; Waage A; Avivi I; Rodzaj M; Leleu X; Richez V; Knopińska-Posłuszny W; Masternak A; Yee AJ; Barchnicka A; Druzd-Sitek A; Guerrero-Garcia T; Liu J; Vesole DH; Castillo JJ
    Br J Haematol; 2018 Mar; 180(6):831-839. PubMed ID: 29315478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autologous Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction: A Systematic Review and Meta-analysis.
    Dhakal B; Szabo A; Chhabra S; Hamadani M; D'Souza A; Usmani SZ; Sieracki R; Gyawali B; Jackson JL; Asimakopoulos F; Hari PN
    JAMA Oncol; 2018 Mar; 4(3):343-350. PubMed ID: 29302684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A role for bone turnover markers β-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma.
    Vallet S; Hoyle NR; Kyle RA; Podar K; Pecherstorfer M
    Leuk Lymphoma; 2018 Oct; 59(10):2431-2438. PubMed ID: 29345175
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance.
    Kyle RA; Larson DR; Therneau TM; Dispenzieri A; Kumar S; Cerhan JR; Rajkumar SV
    N Engl J Med; 2018 Jan; 378(3):241-249. PubMed ID: 29342381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improvement in Overall Survival With Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma.
    Siegel DS; Dimopoulos MA; Ludwig H; Facon T; Goldschmidt H; Jakubowiak A; San-Miguel J; Obreja M; Blaedel J; Stewart AK
    J Clin Oncol; 2018 Mar; 36(8):728-734. PubMed ID: 29341834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update.
    Anderson K; Ismaila N; Flynn PJ; Halabi S; Jagannath S; Ogaily MS; Omel J; Raje N; Roodman GD; Yee GC; Kyle RA
    J Clin Oncol; 2018 Mar; 36(8):812-818. PubMed ID: 29341831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma.
    Gertz MA; Buadi FK; Hayman SR; Lacy MQ; Dispenzieri A; Dingli D; Gonsalves WI; Kumar S; Kapoor P; Kourelis T; Hogan WJ
    Mayo Clin Proc; 2018 Jan; 93(1):56-58. PubMed ID: 29304921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carfilzomib for relapsed or refractory multiple myeloma - Authors' reply.
    Dimopoulos MA; Kimball AS
    Lancet Oncol; 2018 Jan; 19(1):e2. PubMed ID: 29304357
    [No Abstract]   [Full Text] [Related]  

  • 58. Optimizing therapy for del(17p) multiple myeloma.
    Avet-Loiseau H; Richardson PG; di Bacco A
    Oncotarget; 2017 Dec; 8(66):109859-109860. PubMed ID: 29299113
    [No Abstract]   [Full Text] [Related]  

  • 59. Multiple Myeloma: The Case of the Disappearing Band.
    Mamone L; Jones J; Liu S; Li Y; Goldsmith B; Khan AI
    Lab Med; 2017 Dec; 49(1):87-91. PubMed ID: 29309675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pellat-Deceunynk C, Amiot M, Bataille R, et al. Human myeloma cell lines as a tool for studying the biology of multiple myeloma: a reappraisal 18 years after.
    Blood; 2018 Jan; 131(1):154. PubMed ID: 29301776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.